NeoGenomics
(NASDAQ) NEO
NeoGenomics Financials at a Glance
Market Cap
$1.46B
Revenue (TTM)
$745.97M
Net Income (TTM)
-$99.21M
EPS (TTM)
-$0.77
P/E Ratio
-14.49
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$11.47
Volume
3,521,948.367
Open
$11.14
Price
$11.47
Volume
3,521,948.367
Open
$11.14
Previous Close
$11.47
Daily Range
$11.13 - $11.68
52-Week Range
$4.72 - $13.74
Estimated Earnings Date
Jul 28, 2026
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$11.47
Volume
3,521,948.367
Open
$11.14
Previous Close
$11.47
Daily Range
$11.13 - $11.68
52-Week Range
$4.72 - $13.74
Estimated Earnings Date
Jul 28, 2026
NEO News
NEO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NeoGenomics
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
2,500
CEO
Anthony P. Zook
Website
www.neogenomics.comHeadquarters
Fort Myers, FL 33912, US
NEO Financials
Key Financial Metrics (TTM)
Gross Margin
42.13%
Operating Margin
-13.94%
Net Income Margin
-13.30%
Return on Equity
-11.82%
Return on Capital
-5.05%
Return on Assets
-7.37%
Earnings Yield
-6.90%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.46B
Shares Outstanding
130.21M
Volume
3.52M
Avg. Volume
2.22M
Financials (TTM)
Gross Profit
$314.28M
Operating Income
-$104.02M
EBITDA
-$33.55M
Operating Cash Flow
$22.42M
Capital Expenditure
-$27.51M
Free Cash Flow
-$5.09M
Cash & ST Invst.
$146.14M
Total Debt
$408.53M
NeoGenomics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$186.67M
+11.1%
Gross Profit
$80.86M
+10.4%
Gross Margin
43.32%
N/A
Market Cap
$1.46B
N/A
Market Cap/Employee
$662.90K
N/A
Employees
2,200
N/A
Net Income
-$17.11M
+34.0%
EBITDA
-$567.00K
+91.0%
Quarterly Fundamentals
Total Cash
$146.14M
-59.2%
Total Debt
$408.53M
-32.5%
Accounts Receivable
$167.42M
+10.7%
Inventory
$29.84M
+0.2%
Long Term Debt
$403.70M
+0.8%
Short Term Debt
$4.83M
-97.6%
Return on Assets
-7.37%
N/A
Return on Invested Capital
-8.24%
N/A
Free Cash Flow
-$13.14M
+56.0%
Operating Cash Flow
-$8.14M
+67.9%